Clinical TrialsZanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Zanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Read Post »
Clinical TrialsTaltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Taltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Read Post »
New Drug ApprovalFirst New ET Treatment in Nearly 30 Years: BESREMi Wins FDA Approval First New ET Treatment in Nearly 30 Years: BESREMi Wins FDA Approval Read Post »
Clinical TrialsRepatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Repatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Read Post »
Clinical TrialsNew Data Reinforce Vutrisiran Benefit Across ATTR-CM Patient Groups New Data Reinforce Vutrisiran Benefit Across ATTR-CM Patient Groups Read Post »
Clinical TrialsKey QRX003 Interim Results Reveal Improvement in Netherton Syndrome Key QRX003 Interim Results Reveal Improvement in Netherton Syndrome Read Post »
Clinical TrialsCamzyos Shows Strong Five-Year Results in Patients With oHCM Camzyos Shows Strong Five-Year Results in Patients With oHCM Read Post »
New Drug ApprovalNew Hope for Polycythemia Vera: FDA Approves MIMRYLO New Hope for Polycythemia Vera: FDA Approves MIMRYLO Read Post »
Clinical TrialsCRISPR-Cas9 Therapy CTX310 Shows Durable Lipid Lowering Through 1 Year CRISPR-Cas9 Therapy CTX310 Shows Durable Lipid Lowering Through 1 Year Read Post »
Clinical TrialsAficamten Improves Exercise Capacity and Health Status in Nonobstructive HC... Aficamten Improves Exercise Capacity and Health Status in Nonobstructive HC... Read Post »
Clinical TrialsMiv-cel CAR T Therapy Shows Promise in Refractory RA Miv-cel CAR T Therapy Shows Promise in Refractory RA Read Post »
New Drug ApprovalFDA Approves Bixlenvo, First Single-Tablet HIV Regimen for Patients on Comp... FDA Approves Bixlenvo, First Single-Tablet HIV Regimen for Patients on Comp... Read Post »
New Drug ApprovalFDA Approves LISRAYA as First Targeted Oral Therapy for Adults with Dermato... FDA Approves LISRAYA as First Targeted Oral Therapy for Adults with Dermato... Read Post »
Clinical TrialsPaxalisib Shows Early Clinical Activity in Advanced TNBC Paxalisib Shows Early Clinical Activity in Advanced TNBC Read Post »
New Drug ApprovalModerna Secures FDA Approval for XFG-Updated Spikevax and mNEXSPIKE for 202... Moderna Secures FDA Approval for XFG-Updated Spikevax and mNEXSPIKE for 202... Read Post »
New Drug ApprovalHUTCHMED Secures NMPA Conditional Approval for ATLED® (Fanregratinib) in F... HUTCHMED Secures NMPA Conditional Approval for ATLED® (Fanregratinib) in F... Read Post »
Clinical TrialsiECURE Reports 74% Reduction in Hyperammonemic Crises With ECUR-506 in OTC ... iECURE Reports 74% Reduction in Hyperammonemic Crises With ECUR-506 in OTC ... Read Post »
Clinical TrialsCorvus’ Soquelitinib Shows Durable Activity in T-Cell Lymphoma, Supportin... Corvus’ Soquelitinib Shows Durable Activity in T-Cell Lymphoma, Supportin... Read Post »
Clinical TrialsPositive CROSSING Results Expand Tezspire’s Potential in Eosinophilic Eso... Positive CROSSING Results Expand Tezspire’s Potential in Eosinophilic Eso... Read Post »
ResearchStopping Statins After 75: What a New Randomized Trial Found Stopping Statins After 75: What a New Randomized Trial Found Read Post »
Clinical TrialsSpyre’s SPY072 Shows Efficacy Signals in Rheumatoid Arthritis, but Falls ... Spyre’s SPY072 Shows Efficacy Signals in Rheumatoid Arthritis, but Falls ... Read Post »
Clinical TrialsCan a New Cell-Based Transplant Repair Severe Eye Damage from Aniridia-Rela... Can a New Cell-Based Transplant Repair Severe Eye Damage from Aniridia-Rela... Read Post »
New Drug ApprovalRevolution Medicines’ RASONQUE (Daraxonrasib) Becomes First Approved RAS(... Revolution Medicines’ RASONQUE (Daraxonrasib) Becomes First Approved RAS(... Read Post »
Clinical TrialsTRB-061 Shows Treg Activation and Expansion in Phase 1a Study, Supporting A... TRB-061 Shows Treg Activation and Expansion in Phase 1a Study, Supporting A... Read Post »
Clinical TrialsCelcuity Submits sNDA to FDA for REVTORPYK in PIK3CA-Mutant Advanced Breast... Celcuity Submits sNDA to FDA for REVTORPYK in PIK3CA-Mutant Advanced Breast... Read Post »
Clinical TrialsNeurocrine Gets FDA Clearance for Phase 2 NBI-1117567 Alzheimer’s Study Neurocrine Gets FDA Clearance for Phase 2 NBI-1117567 Alzheimer’s Study Read Post »
Clinical TrialsAriBio’s AR1005 Improves Cognitive Fluctuations in Interim Phase 2a D... AriBio’s AR1005 Improves Cognitive Fluctuations in Interim Phase 2a D... Read Post »
New Drug ApprovalFDA Approves Tivicay PD for HIV-1 Treatment in Babies from Birth FDA Approves Tivicay PD for HIV-1 Treatment in Babies from Birth Read Post »
Clinical TrialsApollo Therapeutics Reports Positive Part A Immunogenicity Data for Pan-Rhi... Apollo Therapeutics Reports Positive Part A Immunogenicity Data for Pan-Rhi... Read Post »
New Drug ApprovalZiihera Plus Tislelizumab Approved for HER2-Positive GEA Without PD-L1 Requ... Ziihera Plus Tislelizumab Approved for HER2-Positive GEA Without PD-L1 Requ... Read Post »
Clinical TrialsLong-Term Real-World Data Show Sustained Disease Stabilization with Arimocl... Long-Term Real-World Data Show Sustained Disease Stabilization with Arimocl... Read Post »
Clinical TrialsRezpegaldesleukin Delivers Positive Phase 2b Results in Atopic Dermatitis, ... Rezpegaldesleukin Delivers Positive Phase 2b Results in Atopic Dermatitis, ... Read Post »
Clinical TrialsIvonescimab Plus Chemotherapy Extends Progression-Free Survival After Third... Ivonescimab Plus Chemotherapy Extends Progression-Free Survival After Third... Read Post »
New Drug ApprovalGC Green Cross Secures Hunterase Approvals for Hunter Syndrome in India and... GC Green Cross Secures Hunterase Approvals for Hunter Syndrome in India and... Read Post »
New Drug ApprovalORZEYFUL Approved in Japan as First and Only Medicine to Treat the Underlyi... ORZEYFUL Approved in Japan as First and Only Medicine to Treat the Underlyi... Read Post »
Clinical TrialsInotuzumab Ozogamicin Shows 71% Response Rate in Children with Very High-Ri... Inotuzumab Ozogamicin Shows 71% Response Rate in Children with Very High-Ri... Read Post »
Clinical TrialsNovel Four-Drug Combination Shows Robust Activity Against Metastatic PDAC Novel Four-Drug Combination Shows Robust Activity Against Metastatic PDAC Read Post »
ResearchNRG5051 Targets mPTP Through Novel NLRX1 Mechanism in ALS NRG5051 Targets mPTP Through Novel NLRX1 Mechanism in ALS Read Post »
New Drug ApprovalFDA Approves IMAAVY® (nipocalimab-aahu) as the First Approved Treatment fo... FDA Approves IMAAVY® (nipocalimab-aahu) as the First Approved Treatment fo... Read Post »
Clinical TrialsFDA Places Clinical Hold on REGENXBIO’s RGX-121 After Spine MRI Findings ... FDA Places Clinical Hold on REGENXBIO’s RGX-121 After Spine MRI Findings ... Read Post »
Clinical TrialsTrastuzumab Rezetecan Extends Progression-Free Survival to 30.6 Months in H... Trastuzumab Rezetecan Extends Progression-Free Survival to 30.6 Months in H... Read Post »
New Drug ApprovalHibsago (Bepirovirsen) Approved in Japan as First Functional Cure Treatment... Hibsago (Bepirovirsen) Approved in Japan as First Functional Cure Treatment... Read Post »
Clinical TrialsMazdutide Produces Up to 18.1% Weight Loss in US Phase 2 Obesity Trial Mazdutide Produces Up to 18.1% Weight Loss in US Phase 2 Obesity Trial Read Post »
New Drug ApprovalNICE Recommends Weekly Insulin Efsitora Alfa That Could Cut Injections From... NICE Recommends Weekly Insulin Efsitora Alfa That Could Cut Injections From... Read Post »
Clinical TrialsBelzutifan-Lenvatinib Improves Progression-Free Survival in Previously Trea... Belzutifan-Lenvatinib Improves Progression-Free Survival in Previously Trea... Read Post »
ResearchOrganoids Are Reshaping Drug Development as Research Moves from Animal Stud... Organoids Are Reshaping Drug Development as Research Moves from Animal Stud... Read Post »
ResearchSafety of Experimental Gene and Cell Therapies Under Scrutiny: What Recent ... Safety of Experimental Gene and Cell Therapies Under Scrutiny: What Recent ... Read Post »
Clinical TrialsCefixime Adds No Benefit to Azithromycin in Large Typhoid Trial, Reinforcin... Cefixime Adds No Benefit to Azithromycin in Large Typhoid Trial, Reinforcin... Read Post »
New Drug ApprovalFDA Grants PMA to Implantica’s RefluxStop® for GERD Treatment FDA Grants PMA to Implantica’s RefluxStop® for GERD Treatment Read Post »
Clinical TrialsZalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Zalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Read Post »
